News

O’Neal Cancer Service Line Strategic Initiatives Manager Dorothea Staursky recently testified in front of Congress to support federal funding for the C.W. Bill Young Cell Transplantation Program.

The O’Neal Comprehensive Cancer Center’s Dorothea Staursky urges Congress to approve a budget increase for a program that helps find matching bone marrow donors for people with leukemia and other blood disorders.

Rebecca Arend, M.D., will join Drs. Narendra Wajapeyee and Suzanne Lapi as Co-Leader of the O’Neal Experimental Therapeutics Research Program.

Rashad Hayes answers questions about his cancer journey and experience as a patient of the O'Neal Comprehensive Cancer Center.

Becker’s Healthcare has named UAB Medicine as one of the nation’s 150 Top Places to Work in Healthcare for 2023. This annual list highlights hospitals, health systems, and medical centers that set themselves apart in the industry by investing in employees’ well-being, satisfaction, and fulfillment.

The O’Neal Comprehensive Cancer Center at UAB will host the State of the O’Neal Comprehensive Cancer Center on Friday, May 12, at 3 p.m. in the Margaret Cameron Spain Auditorium. Director Barry Sleckman, M.D., Ph.D., will review the Cancer Center’s growth and highlight accomplishments from the last year.

The O’Neal Comprehensive Cancer Center at UAB would like to welcome Zaid Al-Kadhimi, M.D., the new director of the Blood and Marrow Transplantation and Cell Therapy Program in the UAB Heersink School of Medicine’s Division of Hematology & Oncology.

The O’Neal Comprehensive Cancer Center at UAB launched a new website that creates a virtual front door to UAB Medicine’s world-class cancer care, research, and patient support services.

The University of Alabama at Birmingham is partnering with Bibb Medical Center to provide care to rural patients. The partnership will provide screening and diagnostic modalities for colon and stomach cancers, in addition to reflux disease and swallowing difficulty.

Blazer Bolt Inc. is a 501(c)(3) organization whose annual event is the Blazer Bolt for Brain Cancer, which is a race created to support those battling brain cancer. All proceeds will directly benefit the UAB Division of Neuro-Oncology and Children’s of Alabama Neuro-Oncology, to help fund adult and pediatric brain cancer research and patient support services.

In observance of National Cancer Prevention Month in February, three UAB patients share their experiences about how getting recommended prostate screenings helps save lives.

The O'Neal Comprehensive Cancer Center's Cancer Training & Career Development Office is proud to partner with Birmingham City Schools and Birmingham Promise to support young researchers like Kamari Marzette, who is featured in a recent commercial filmed in Wallace Tumor Institute.

In November 2020, retired Chief Master Sergeant Patrick McCrocklin visited the medical center at Maxwell Air Force Base in Montgomery, Ala., where he assumed he would be treated for a hernia. He actually had two hernias, but doctors also found two mysterious spots on his liver. MRI and PET scans revealed stage 4 colorectal cancer that had spread to his liver, and he was given just six months to live.

Providing comprehensive care for patients during their cancer journey includes helping them maintain their mental well-being – before, during, and after treatment. To help meet that need, the O’Neal Comprehensive Cancer Center at UAB (OCCC) hosts online support groups for patients with specific types of cancer, as well as a new group for those with any type of cancer.

David Cole answers questions about his cancer journey and experience as a patient of the O'Neal Comprehensive Cancer Center.

The University of Alabama at Birmingham Digestive Health Center will offer free colonoscopies to select patients of Cooper Green Mercy Health Services Authority through a grant from the Alabama Department of Public Health during Colorectal Cancer Awareness Month in March.

The O’Neal Comprehensive Cancer Center at UAB will host the inaugural Edward E. Partridge, M.D., Lecture on Wednesday, April 5, at noon in Wallace Tumor Institute, Room 101. Phillip E. Castle, Ph.D., MPH, director of the Division of Cancer Prevention at the National Cancer Institute, will present “Human Papillomavirus and Cervical Cancer: At the Crossroads for Global Health Equity.”

The O’Neal Comprehensive Cancer Center at UAB recently awarded six projects a total of $530,000 in research grants through O'Neal Invests. The O’Neal Invests program funds UAB investigators initiating new cancer-related projects to do key, preliminary work in order to enable competitive R01 applications.

The Breast Cancer Research Foundation of Alabama recently awarded eight researchers at the O’Neal Comprehensive Cancer Center at UAB a total of $800,000 in breast cancer research funding.

O'Neal Cancer Center Scientist Mehmet Akce, M.D., has been named the leader of the O’Neal Precision Medicine Working Group and Associate Director for Precision Oncology of the Hugh Kaul Precision Medicine Institute.

The Breast Cancer Research Foundation of Alabama recently awarded $320,000 in funding to two researchers at the O'Neal Cancer Center.

The Oral Oncology Clinic at the University of Alabama at Birmingham is taking patient imaging beyond flat screens with the new Brainlab Mixed Reality Viewer. This new platform uses mixed reality technology to showcase a hyper-realistic 3D view of patients’ head and neck tumors.

Certain cancer treatments can damage the heart and the cardiovascular system. The cardio-oncology clinic at the O’Neal Comprehensive Cancer Center at Acton Road is addressing that problem. The clinic offers comprehensive testing and specialized care to protect cancer patients undergoing therapies that can affect cardiovascular function.

The University of Alabama at Birmingham has been designated a Center of Excellence by the American Initiative in Mast Cell Diseases Network. Mast cells are produced in the bone marrow and are an important part of the immune system. Mast cell diseases, such as mastocytosis, occur from an overabundance or overactivity of mast cells in the bone marrow and other organs.